CA3016870C - Anticorps anti-tnf.alpha. et fragments fonctionnels de ceux-ci - Google Patents

Anticorps anti-tnf.alpha. et fragments fonctionnels de ceux-ci

Info

Publication number
CA3016870C
CA3016870C CA3016870A CA3016870A CA3016870C CA 3016870 C CA3016870 C CA 3016870C CA 3016870 A CA3016870 A CA 3016870A CA 3016870 A CA3016870 A CA 3016870A CA 3016870 C CA3016870 C CA 3016870C
Authority
CA
Canada
Prior art keywords
antibody
tnfa
amino acid
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3016870A
Other languages
English (en)
Other versions
CA3016870A1 (fr
Inventor
Tea Gunde
Sebastian Meyer
Original Assignee
Numab Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Numab Therapeutics AG filed Critical Numab Therapeutics AG
Priority claimed from PCT/EP2017/056254 external-priority patent/WO2017158101A1/fr
Publication of CA3016870A1 publication Critical patent/CA3016870A1/fr
Application granted granted Critical
Publication of CA3016870C publication Critical patent/CA3016870C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des molécules d'anticorps et des fragments fonctionnels de celles-ci, capables de se lier au facteur de nécrose tumorale (TNFa). L'invention concerne également des procédés de production desdites molécules d'anticorps et leurs utilisations thérapeutiques.
CA3016870A 2016-03-17 2017-03-16 Anticorps anti-tnf.alpha. et fragments fonctionnels de ceux-ci Active CA3016870C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16000653 2016-03-17
EP16000653.2 2016-03-17
PCT/EP2017/056254 WO2017158101A1 (fr) 2016-03-17 2017-03-16 Anticorps anti-tnfα et fragments fonctionnels de ceux-ci

Publications (2)

Publication Number Publication Date
CA3016870A1 CA3016870A1 (fr) 2017-09-21
CA3016870C true CA3016870C (fr) 2025-09-09

Family

ID=

Similar Documents

Publication Publication Date Title
US12043663B2 (en) Anti-TNF-alpha-antibodies and functional fragments thereof
KR102474765B1 (ko) 항-TNFα-항체 및 이의 기능성 단편
US10787508B2 (en) Anti-TNFα-antibodies and functional fragments thereof
US10759852B2 (en) Anti-TNF-alpha-antibodies and functional fragments thereof
US10774140B2 (en) Anti-TNFα-antibodies and functional fragments thereof
CA3016870C (fr) Anticorps anti-tnf.alpha. et fragments fonctionnels de ceux-ci
CA3011500C (fr) Anticorps anti-tnfa et fragments fonctionnels correspondants
HK40001673A (en) Anti-tnfalpha-antibodies and functional fragments thereof
HK40001673B (en) Anti-tnfalpha-antibodies and functional fragments thereof